QIAGEN launches syndromic test for QIAstat-Dx device to combat Monkeypox health emergency
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
Lupin is the 6th largest company in the Indian Pharmaceutical Market
He was appointed a Board member and the Chairman in 2012.
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Subscribe To Our Newsletter & Stay Updated